Importantly, this study demonstrated that blocking STAT3 in vitro inhibited norepinephrine-induced pancreatic cancer cell migration, invasion, and PNI, and that treatment with a STAT3 phosphorylation inhibitor blocked PNI of pancreatic cancer cells in vivo. This evidence concerns the gene STAT3 and pancreatic neoplasm.